| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T431 |
0-148 |
Sentence |
denotes |
Data on the use of corticosteroids in critically ill patients with SARS-CoV-1 and MERS-CoV infection are available, albeit with conflicting results. |
| T432 |
149-397 |
Sentence |
denotes |
In a retrospective observational study of 152 SARS-CoV-1–infected, critically ill patients, corticosteroid therapy was found to reduce mortality and shorten the length of hospital stay (odds ratio 0.08, 95% confidence intervals 0.01–0.97, p 0.046). |
| T433 |
398-517 |
Sentence |
denotes |
The study did not report increased secondary infections or other complications with corticosteroid administration [64]. |
| T434 |
518-752 |
Sentence |
denotes |
Conversely, in a retrospective observational study on 309 critically ill patients with MERS-CoV, the administration of a median hydrocortisone equivalent dose of 300 mg per day was not associated with a difference in 90-day mortality. |
| T435 |
753-892 |
Sentence |
denotes |
In addition, corticosteroid administration was associated with delayed clearance of MERS-CoV RNA from the patients' respiratory tract [65]. |
